Transient postoperative vascular endothelial growth factor (VEGF)-neutralisation improves graft survival in corneas with partly regressed inflammatory neovascularisation

Transient postoperative vascular endothelial growth factor (VEGF)-neutralisation improves graft survival in corneas with partly regressed inflammatory neovascularisation
复制标题

DOI:
10.1136/bjo.2008.145128
复制
发表时间:
2009-08-01
影响因子:
4.1
通讯作者:
Cursiefen, C.
Cursiefen, C.
中科院分区:
医学2区
文献类型:
--
作者:
Bachmann, B. O.;Luetjen-Drecoll, E.;Cursiefen, C.

文献摘要

被引文献

相似文献

背景资料:高危角膜移植术通常在无炎症和静止期后进行,角膜的血管和淋巴管部分消退。我们分析了在具有部分退化角膜血管(“中等风险”)的小鼠中抑制角膜移植术后血管再生是否改善移植物存活率。方法:在Balb/c小鼠(6-8周龄)的角膜中放置三个间断的基质缝线(11-0)6周。拆线后6个月,用C57 BL/6供体进行穿透性角膜移植术。治疗组在角膜移植术后第0、4、7和14天腹膜内接受血管内皮生长因子-A特异性细胞因子捕获物(VEGF捕获物)(每只小鼠25 mg/kg;对照接受等量的Fc蛋白)。病理血管生成和淋巴管生成之前,以及3天或8周后角膜移植术和移植物survival.Results:角膜移植术后3天角膜血运重建充分减少VEGF陷阱(血管化面积减少42.7%,淋巴血管化面积减少54.7%)。角膜移植术后8周的存活率,治疗组为36%,对照组为9%(n = 11; p
Background: High-risk keratoplasties are usually performed after an uninflamed and quiescent interval in corneas with partly regressed blood and lymphatic vessels. We analysed whether the inhibition of post-keratoplasty revascularisation in mice with partly regressed corneal vessels ("intermediate-risk'') improves graft survival.Methods: Three interrupted stromal sutures (11-0) in corneas of Balb/c mice (6-8 weeks old) were placed for 6 weeks. Six months after suture removal, penetrating keratoplasty was performed with C57BL/6 donors. The treatment group received a vascular endothelial growth factor-A specific cytokine trap (VEGF Trap) intraperitoneally at days 0, 4, 7 and 14 after keratoplasty (25 mg/kg per mouse; controls received equal amounts of Fc protein). Pathological haemangiogenesis and lymphangiogenesis prior to as well as 3 days or 8 weeks after keratoplasty and graft survival were analysed.Results: Three days after keratoplasty corneal revascularisation was sufficiently reduced by VEGF Trap (haemvascularised areas 42.7% reduction; lymph-vascularised areas 54.7% reduction). Survival proportions 8 weeks after keratoplasty were 36% in the treatment group compared with 9% in the control group (n = 11; p